Vibhavadi Medical Center PCL (BKK:VIBHA-R) YoY EBITDA Growth: 50.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:VIBHA-R Vibhavadi Medical Center PCL BKK:VIBHA-R
70 GF Score
Price ฿1.36
GF Value ฿1.65
! 5 Warning Signs
View Full Analysis

What is Vibhavadi Medical Center PCL YoY EBITDA Growth?

Vibhavadi Medical Center PCL BKK:VIBHA-R 70 YoY EBITDA Growth is 50.00% as of Mar. 2026. GuruFocus rates BKK:VIBHA-R with a GF Score™ of 70/100 and a GF Value™ of ฿1.65. The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Vibhavadi Medical Center PCL's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 50.00%.

Vibhavadi Medical Center PCL's EBITDA per Share for the three months ended in Mar. 2026 was ฿0.02.

Vibhavadi Medical Center PCL YoY EBITDA Growth Related Terms

Vibhavadi Medical Center PCL YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Vibhavadi Medical Center PCL's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vibhavadi Medical Center PCL YoY EBITDA Growth Chart

Vibhavadi Medical Center PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 117.78 6.12 -21.15 -28.66 82.91

Vibhavadi Medical Center PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -66.67 9.38 -30.36 680.00 50.00
BKK:VIBHA-R
70GF Score
Vibhavadi Medical Center PCL BKK:VIBHA-R
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vibhavadi Medical Center PCL YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Vibhavadi Medical Center PCL's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.214-0.117)/ | 0.117 |
=82.91 %

Vibhavadi Medical Center PCL's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(0.024-0.016)/ | 0.016 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 50.00% mean?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a YoY EBITDA Growth of 50.00% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Vibhavadi Medical Center PCL and its competitors.
Is Vibhavadi Medical Center PCL's YoY EBITDA Growth too high?
Vibhavadi Medical Center PCL's current YoY EBITDA Growth is 50.00%. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's YoY EBITDA Growth compare to HCA and THC?
Vibhavadi Medical Center PCL's YoY EBITDA Growth of 50.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Vibhavadi Medical Center PCL and its competitors. Vibhavadi Medical Center PCL's current YoY EBITDA Growth is 50.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a current YoY EBITDA Growth of 50.00%. The stock's GF Value™ is ฿1.65, compared to a current price of ฿1.36 — trading 17.6% below its estimated fair value. The current YoY EBITDA Growth is 50.00%. Vibhavadi Medical Center PCL's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA-R), the current YoY EBITDA Growth is 50.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vibhavadi Medical Center PCL (BKK:VIBHA-R) Overvalued in 2026?

Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued. The current stock price of ฿1.36 is trading 17.6% below its estimated GF Value™ of ฿1.65.

Key valuation signals for BKK:VIBHA-R:

  • YoY EBITDA Growth: 50.00%
  • GF Value™: ฿1.65 vs. price of ฿1.36 (17.6% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the BKK:VIBHA-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vibhavadi Medical Center PCL Business Description

Other Exchanges VIBHA:Thailand
Address 51/3 Ngam Wong Wan Road, Latyao Sub-District, Chatuchak District, Bangkok, THA, 10900
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
70GF Score

Get the complete analysis for BKK:VIBHA-R

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.36
Price
฿1.65
GF Value